Trials / Completed
CompletedNCT03464175
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation: a Randomized Comparative Scintigraphic Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The intention is to enroll a specific sample of intubated patients. To compare the effect of respiratory gas conditioning on lung deposition and considering the well-known influences of lung pathology on lung deposition, intubated patients with healthy lungs will be included. Postoperative neurosurgery ventilated patients respond perfectly to this criteria. A previous study including 17 postoperative neurosurgery patients was performed in 2013 with a perfect collaboration between the ICU and the Department of Neurosurgery and Anesthesiology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Aerogen Solo® | Aerosol particles are generated by a vibrating-mesh nebulizer specifically designed for mechanical ventilation |
| DEVICE | Heated-humidified circuit | It will be left on during the transfer and the nebulization in group 1 |
| DEVICE | Heated-humidified circuit | It will be turned off 30 minutes before the nebulization (nebulization ended max 45 minutes after turning off the heated-humidifier). |
| DEVICE | Dry ventilator circuit specific for aerosol therapy | Streamlined components, specific position for the nebulizer at 30 cm of a V-shaped Y piece |
| DEVICE | Conventional dry ventilator circuit with HME filter | The nebulizer is placed between the filter and the endotracheal tube. |
Timeline
- Start date
- 2018-01-22
- Primary completion
- 2020-12-15
- Completion
- 2020-12-15
- First posted
- 2018-03-13
- Last updated
- 2022-11-04
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03464175. Inclusion in this directory is not an endorsement.